Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Pre-operative Olanzapine as Prophylactic Antiemetic in Oncologic Patients

NCT03631004 is registered in ClinicalTrials.gov with Instituto do Cancer do Estado de São Paulo as lead sponsor.

NCT NCT03631004
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03631004 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Pre-operative Olanzapine as Prophylactic Antiemetic in Oncologic Patients
Lead sponsor
Instituto do Cancer do Estado de São Paulo
Phase
Phase 2/3
Overall status
Completed
Start date
October 1, 2018
Completion date
February 10, 2021
Enrollment
100 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

postoperative nausea, postoperative nausea and vomiting